IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
<p>Abstract</p> <p>Background</p> <p>Despite inducing a sustained increase in CD4+ T cell counts, intermittent recombinant IL-2 (rIL-2) therapy did not confer a better clinical outcome in HIV-infected patients enrolled in large phase III clinical trials ESPRIT and SILCAAT. Several hypotheses were ev...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2012-09-01
|
| Schriftenreihe: | Virology Journal |
| Schlagworte: | |
| Online-Zugang: | http://www.virologyj.com/content/9/1/220 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|